Having trouble reading this email? View the web version here  |  Forward this email to a colleague

Facebook Like Button Tweet Button
European Pharmaceutical Review

DiscoveRx announces a series of scientific outreach programmes to promote leading edge cell-based and biochemical GPCR and Kinase assays to the European community

To progress the development of novel assay solutions for major drug targets including GPCR’s, kinases and nuclear hormone receptors, DiscoveRx is proud to promote scientific outreach programmes where premier scientists present field leading, innovative research at local universities and research institutes throughout Europe...

Find out more >>

Pharmaceutical & life science news:

Researchers identify genes causing antimalarial drug resistance
Researchers have identified several genes that may be implicated in the malaria parasite's ability to rapidly evade drug treatments...

Pfizer comments on ORAL Sync tofacitinib data
Pfizer has commented on an abstract concerning the ORAL Sync Phase 3 study of tofacitinib in patients with rheumatoid arthritis...

Daiichi Sankyo receives first market approval in Japan for LIXIANA®
LIXIANA® (Edoxaban) is a direct oral factor Xa inhibitor for the prevention of venous thromboembolism...

Idera Pharmaceuticals delays initiation of Phase 2 clinical trial of IMO-2125 in treatment-naïve HCV patients
Delay is based on preliminary data from a 26-week nonclinical toxicology study...

Sanofi Pasteur announces FDA approval of Menactra®
Sanofi Pasteur announces that the FDA has granted licensure to expand the indication for its meningococcal conjugate vaccine...

Merck and Sanofi Pasteur initiate Phase III study in the US of pediatric combination vaccine
Combination vaccine designed to help protect against 6 diseases: diphtheria, tetanus, whooping cough, polio, Haemophilus influenzae type b, and hepatitis B...

Amgen and UCB announce positive phase 2 results of AMG 785/CDP7851 in Patients With PMO
Amgen & UCB announced positive top-line results from their Phase 2 clinical study...

Pfizer and Shanghai Pharmaceutical sign memorandum of understanding for potential strategic partnership
Shanghai Pharmaceutical Co. Ltd. and Pfizer Inc. today announced the signing of a MOU...

Gilead and MicroDose Therapeutx announce license and collaboration agreement to develop MDT-637
Gilead & MicroDose Therapeutx, have entered into an exclusive worldwide license...

FDA approves Roche's HPV test for identifying women at highest risk for cervical cancer
Roche announced that the FDA has approved the cobas HPV (Human Papillomavirus) Test...

Conferences, events & exhibitions:

RDD EUROPE 2011
3 - 6 May 2011 Berlin, Germany

The Future for UK Pharmaceuticals R&D – Innovation through Partnership
12 May 2011 London, UK

Free webinar: Justifying new technology investments in the Micro QC Lab
Tuesday, May 17, 2011, 3:00pm BST
According to various research studies of pharmaceutical quality control professionals, nearly half of micro QC organisations continue to operate using manual processes. During this free webinar, learn from industry experts how to justify an investment in new technology. During this webinar, you will learn the benefits to automating Micro QC processes, the technologies available, the steps to build a business case, and areas of value to include.

QbD for Pharma
24 - 25 May 2011 Berlin, Germany

10th Annual Congress Recombinant Antibodies
24 - 26 May 2011 Barcelona, Spain

Partnering with Central Labs, ECG and Imaging Labs
25 - 26 May 2011 Brussels, Belgium

Pharma Manufacturing Summit 2011
7 - 9 June 2011 Montreux, Switzerland
The NGP Manufacturing Summit will serve as an arena for senior level executives to engage in a clear and focused dialogue with their peers to procure and examine their business and manufacturing objectives in real time. GDS has elected more than 50 of the most well respected executives in the European pharmaceutical industry. The delegation gathers together to spend two days with their peers to network and share knowledge while assessing new technologies available in the marketplace.

12th Annual Drug Discovery Leaders Summit 2011
8 - 9 June 2011 Le Montreux Palace, Montreux, Switzerland

European Lab Automation Congress 2011
30 June - 1 July 2011 Hamburg, Germany

Free webinar: Justifying new technology investments in the Micro QC Lab

Date: Tuesday, May 17, 2011
Time: 3pm BST
Length: One hour

According to various research studies of pharmaceutical quality control professionals, nearly half of micro QC organizations continue to operate using manual processes. Time consuming, manual tasks result in slower throughput of samples and longer quarantine times, placing a burden on the Micro QC department who must perform low value, manual tasks.

New technologies have become available to create a more efficient and effective Micro QC Lab, but companies have been slow to adopt. Concerns on how to create a business case for the new technology create one stumbling block. During this free webinar, learn from industry experts the steps to justify an investment in new technology.

During this webinar, you will learn:

  • Benefits to automating Micro QC processes
  • Technologies available
  • Steps to build a business case
  • Areas of value to include


Join European Pharmaceutical Review on LinkedIn


Follow European Pharmaceutical Review on Twitter